Cardiac failure
Digoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. Its
therapeutic benefit is greatest in those patients with ventricular dilatation.
Digoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation.
Supraventricular arrhythmias
Digoxin is indicated in the management of certain supraventricular arrhythmias, particularly chronic atrial flutter andfibrillation.